Dr. Lori Muffly, MD
Claim this profileStanford Cancer Institute
Area of expertise
Leukemia
Lori Muffly, MD has run 4 trials for Leukemia. Some of their research focus areas include:
Acute Myeloid Leukemia
Lori Muffly, MD has run 4 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Affiliated Hospitals
Stanford Cancer Institute
Stanford University
Clinical Trials Lori Muffly, MD is currently running
Axicabtagene Ciloleucel
for Non-Hodgkin Lymphoma
This is a phase Ib study to establish safety of Axi-Cel-2 in patients with Large B Cell Lymphoma (LBCL) who are at high risk of relapse.
Recruiting
1 award
Phase 1
CAR T-Cell Therapy
for Brain Cancer
This is an open label, non-randomized, single site Phase I study to test the manufacturing feasibility and safety of locoregional (LR) administration of B7-H3CART into the central nervous system of adult subjects with recurrent IDH wild-type GBM using a standard 3+3 dose escalation design.
Recruiting
1 award
Phase 1
More about Lori Muffly, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Lori Muffly, MD has experience with
- Cyclophosphamide
- CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells
- Fludarabine Phosphate
- NKTR-255
- Brexucabtagene Autoleucel
- Dasatinib
Breakdown of trials Lori Muffly, MD has run
Leukemia
Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Acute Myelogenous Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lori Muffly, MD specialize in?
Lori Muffly, MD focuses on Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Leukemia has involved CD19 positive patients, or patients who are CD22 negative.
Is Lori Muffly, MD currently recruiting for clinical trials?
Yes, Lori Muffly, MD is currently recruiting for 2 clinical trials in Stanford California. If you're interested in participating, you should apply.
Are there any treatments that Lori Muffly, MD has studied deeply?
Yes, Lori Muffly, MD has studied treatments such as Cyclophosphamide, CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells, Fludarabine Phosphate.
What is the best way to schedule an appointment with Lori Muffly, MD?
Apply for one of the trials that Lori Muffly, MD is conducting.
What is the office address of Lori Muffly, MD?
The office of Lori Muffly, MD is located at: Stanford Cancer Institute, Stanford, California 94305 United States. This is the address for their practice at the Stanford Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.